Amicus Therapeutics, Inc.
NASDAQ:FOLD
10.99 (USD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 399.356 | 329.233 | 305.514 | 260.886 | 182.237 | 91.245 | 36.93 | 4.958 | 0 | 1.224 | 0.363 | 18.411 | 21.434 | 0.922 | 64.358 | 14.967 | 1.784 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 45.199 | 38.599 | 34.466 | 31.044 | 21.963 | 14.404 | 6.236 | 0.833 | 1.833 | 0 | 13.492 | 20.377 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 354.157 | 290.634 | 271.048 | 229.842 | 160.274 | 76.841 | 30.694 | 4.125 | -1.833 | 1.224 | -13.129 | -1.966 | 21.434 | 0.922 | 64.358 | 14.967 | 1.784 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0.887 | 0.883 | 0.887 | 0.881 | 0.879 | 0.842 | 0.831 | 0.832 | 0 | 1 | -36.168 | -0.107 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 152.381 | 276.677 | 272.049 | 308.443 | 286.378 | 270.902 | 149.31 | 104.793 | 76.943 | 47.624 | 41.944 | 50.273 | 50.856 | 39.042 | 48.081 | 37.764 | 31.074 | 33.63 | 13.652 | 0 | 4.433 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 127.2 | 0 | 71.151 | 47.269 | 20.717 | 18.893 | 19.364 | 19.88 | 15.66 | 19.973 | 19.666 | 15.278 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 275.27 | 213.041 | 192.71 | 156.407 | 169.861 | 127.2 | 88.671 | 71.151 | 47.269 | 20.717 | 18.893 | 19.364 | 19.88 | 15.66 | 19.973 | 19.666 | 15.278 | 12.277 | 6.877 | 0 | 0 |
| Other Expenses
| -15.886 | 5.342 | 6.209 | 8.846 | 4.775 | -5.632 | 6.008 | -4.793 | -0.08 | -0.077 | 1.719 | 0.021 | 1.585 | 2.058 | 2.132 | 1.493 | 1.237 | 0 | 0 | -8.807 | 0 |
| Operating Expenses
| 427.651 | 495.06 | 470.968 | 473.696 | 461.014 | 402.318 | 241.574 | 179.186 | 126.045 | 69.888 | 62.556 | 71.342 | 72.321 | 56.76 | 70.186 | 58.923 | 47.589 | 46.859 | 20.831 | -8.807 | 6.6 |
| Operating Income
| -73.494 | -204.426 | -199.92 | -243.854 | -300.74 | -328.777 | -441.985 | -181.89 | -130.437 | -68.701 | -64.181 | -52.931 | -50.887 | -55.838 | -7.35 | -43.956 | -45.805 | -46.859 | -20.831 | -8.807 | -6.6 |
| Operating Income Ratio
| -0.184 | -0.621 | -0.654 | -0.935 | -1.65 | -3.603 | -11.968 | -36.686 | 0 | -56.128 | -176.807 | -2.875 | -2.374 | -60.562 | -0.114 | -2.937 | -25.675 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -76.607 | -37.613 | -41.634 | -30.4 | -55.17 | -11.671 | -225.097 | -24.924 | -5.424 | -0.114 | -1.08 | 0.674 | 2.834 | -0.133 | -1.458 | 4.601 | -0.149 | -1.203 | -0.28 | 0 | -0.168 |
| Income Before Tax
| -150.101 | -242.039 | -241.554 | -274.254 | -355.91 | -349.089 | -449.121 | -203.781 | -132.118 | -70.039 | -63.145 | -52.03 | -48.041 | -56.075 | -6.567 | -39.355 | -41.167 | -46.345 | -20.584 | 0 | -6.768 |
| Income Before Tax Ratio
| -0.376 | -0.735 | -0.791 | -1.051 | -1.953 | -3.826 | -12.161 | -41.101 | 0 | -57.221 | -173.953 | -2.826 | -2.241 | -60.819 | -0.102 | -2.629 | -23.076 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 1.483 | -5.471 | 8.906 | 2.598 | 0.478 | -0.094 | -165.119 | -3.739 | 1.498 | -1.113 | -3.512 | -3.245 | -3.629 | -1.139 | 0.278 | 0 | 0.351 | -0.514 | -0.612 | 8.807 | 0 |
| Net Income
| -151.584 | -236.568 | -250.46 | -276.852 | -356.388 | -348.995 | -284.002 | -200.042 | -132.118 | -68.926 | -59.633 | -48.785 | -44.412 | -54.936 | -6.567 | -39.355 | -41.167 | -46.345 | -19.972 | -8.807 | -6.768 |
| Net Income Ratio
| -0.38 | -0.719 | -0.82 | -1.061 | -1.956 | -3.825 | -7.69 | -40.347 | 0 | -56.312 | -164.278 | -2.65 | -2.072 | -59.584 | -0.102 | -2.629 | -23.076 | 0 | 0 | 0 | 0 |
| EPS
| -0.51 | -0.82 | -0.92 | -1.07 | -1.48 | -1.88 | -1.85 | -1.49 | -1.2 | -0.93 | -1.16 | -1.07 | -1.28 | -1.98 | -0.29 | -1.75 | -3.11 | -62.97 | -48.69 | -28.64 | -22.01 |
| EPS Diluted
| -0.51 | -0.82 | -0.92 | -1.07 | -1.48 | -1.88 | -1.85 | -1.49 | -1.2 | -0.93 | -1.16 | -1.07 | -1.28 | -1.98 | -0.29 | -1.75 | -3.11 | -62.97 | -48.69 | -28.64 | -22.01 |
| EBITDA
| -65.621 | -191.884 | -196.103 | -232.563 | -328.966 | -316.432 | -197.183 | -175.01 | -123.363 | -66.971 | -60.3 | -50.889 | -49.142 | -53.624 | -2.699 | -42.463 | -44.419 | -44.703 | -19.883 | -8.807 | -6.468 |
| EBITDA Ratio
| -0.164 | -0.583 | -0.642 | -0.891 | -1.805 | -3.468 | -5.339 | -35.299 | 0 | -54.715 | -166.116 | -2.764 | -2.293 | -58.161 | -0.042 | -2.837 | -24.899 | 0 | 0 | 0 | 0 |